Characterization of Hippo Pathway Components by Gene Inactivation.

[1]  Bin Zhao,et al.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer , 2015, Cell.

[2]  G. Halder,et al.  MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway , 2015, Nature Communications.

[3]  K. Guan,et al.  Opposing roles of conventional and novel PKC isoforms in Hippo-YAP pathway regulation , 2015, Cell Research.

[4]  M. Karin,et al.  A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis , 2015, Genes & development.

[5]  H. Nojima,et al.  Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP , 2015, Genes & development.

[6]  Mingjie Zhang,et al.  Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway , 2015, Cell Research.

[7]  K. Guan,et al.  Disease implications of the Hippo/YAP pathway. , 2015, Trends in molecular medicine.

[8]  K. Guan,et al.  Hippo pathway regulation of gastrointestinal tissues. , 2015, Annual review of physiology.

[9]  K. Guan,et al.  Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway , 2015, Nature Cell Biology.

[10]  Randy L. Johnson,et al.  AMPK modulates Hippo pathway activity to regulate energy homeostasis , 2015, Nature Cell Biology.

[11]  Y. Ip,et al.  The conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila. , 2014, Developmental cell.

[12]  Jonathan A. Cooper,et al.  Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. , 2014, Cancer cell.

[13]  A. Schulz,et al.  A neuronal function of the tumor suppressor protein merlin , 2014, Acta neuropathologica communications.

[14]  Neville E. Sanjana,et al.  Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.

[15]  Yonggang Zheng,et al.  Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2 , 2013, Cell.

[16]  Noor B. Dawany,et al.  The p130 Isoform of Angiomotin Is Required for Yap-Mediated Hepatic Epithelial Cell Proliferation and Tumorigenesis , 2013, Science Signaling.

[17]  P. Wierzbicki,et al.  Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation. , 2013, World journal of gastroenterology.

[18]  David M. Thomas,et al.  The Hippo pathway and human cancer , 2013, Nature Reviews Cancer.

[19]  Satoshi O. Suzuki,et al.  Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. , 2012, The Journal of clinical investigation.

[20]  G. Bonamy,et al.  Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. , 2012, Chemistry & biology.

[21]  Xiang-Dong Fu,et al.  Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling , 2012, Cell.

[22]  Q. Ou,et al.  Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer. , 2012, European journal of cancer.

[23]  K. Harvey,et al.  The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway. , 2011, Developmental cell.

[24]  R. Fehon,et al.  Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway. , 2011, Developmental cell.

[25]  J. Yates,et al.  Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor , 2011, Molecular biology of the cell.

[26]  A. Pobbati,et al.  Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin* , 2011, The Journal of Biological Chemistry.

[27]  Junjie Chen,et al.  Angiomotin-like Proteins Associate with and Negatively Regulate YAP1* , 2010, The Journal of Biological Chemistry.

[28]  D. Pan,et al.  The hippo signaling pathway in development and cancer. , 2010, Developmental cell.

[29]  Zhengyu Zha,et al.  The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase* , 2010, The Journal of Biological Chemistry.

[30]  E. Wang,et al.  Overexpression of yes‐associated protein contributes to progression and poor prognosis of non‐small‐cell lung cancer , 2010, Cancer science.

[31]  G. Longmore,et al.  Ajuba LIM Proteins Are Negative Regulators of the Hippo Signaling Pathway , 2010, Current Biology.

[32]  S. Vandenberg,et al.  The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. , 2008, Neoplasia.

[33]  Marcel H. Schulz,et al.  A Global View of Gene Activity and Alternative Splicing by Deep Sequencing of the Human Transcriptome , 2008, Science.

[34]  Jiandie D. Lin,et al.  TEAD mediates YAP-dependent gene induction and growth control. , 2008, Genes & development.

[35]  J. Avruch,et al.  MOBKL1A/MOBKL1B Phosphorylation by MST1 and MST2 Inhibits Cell Proliferation , 2008, Current Biology.

[36]  Li Li,et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.

[37]  G. Feldmann,et al.  Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.

[38]  D. Vaux,et al.  Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C‐terminal coiled‐coil domains, leads to its stabilization and phosphorylation , 2006, The FEBS journal.

[39]  Jianbin Huang,et al.  The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP , 2005, Cell.

[40]  E. Nigg,et al.  The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1 , 2005, Oncogene.

[41]  D. Haber,et al.  salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines , 2002, Cell.

[42]  Yonggang Zheng,et al.  Identification of Happyhour / MAP 4 K as Alternative Hpo / Mst-like Kinases in the Hippo Kinase Cascade Graphical , 2015 .

[43]  K. Guan,et al.  Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. , 2011, Genes & development.

[44]  K. Guan,et al.  A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). , 2010, Genes & development.